Hydrophobic interaction of lysophospholipids and bile salts at submicellar concentrations
- PMID: 2383561
- DOI: 10.1021/bi00476a027
Hydrophobic interaction of lysophospholipids and bile salts at submicellar concentrations
Abstract
A series of environment-sensitive, fluorescent-labeled N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-monoacylphosphatidylethano lamine (N-NBD-lysoPE) probes of differing acyl chain length (C12-C18) was used to demonstrate the hydrophobic interaction between lysophospholipids and two different bile salts at concentrations below their respective critical micelle concentrations (cmc's). Formation of submicellar aggregates in the presence of bile salt-phospholipid mixed micelles could facilitate lipid absorption in the intestine. To ensure the use of submicellar lysolipid concentrations in the experiments, the cmc of each fluorescent lysolipid probe was determined by concentration-dependent self-quenching. The cmc values obtained for the various N-NBD-lysoPE probes were as follows (microM): monolauroyl, greater than or equal to 40; monomyristoyl, 4; monopalmitoyl, 0.3; monostearoyl, 0.04. Probe concentrations well below their respective cmc's were used in all experiments. The fluorescence of a solution of each lysolipid probe was monitored as the concentration of bile salt was gradually increased. The increase in fluorescence was taken as a measure of the ability of the bile salt molecules to complex with the probe molecule, thereby increasing the fluorescent yield of the lysolipid probe molecule. Determination of the cmc of the bile salts in the presence of the lysolipid probe was made in parallel with the fluorescence measurement by monitoring the increase in light scattering of the solution. Both bile salts were shown to induce maximal increases in fluorescence of the N-NBD-lysoPE derivatives at concentrations of bile salt well below their respective cmc values, indicating the existence of submicellar lysolipid-bile salt aggregates.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Time-resolved fluorescence anisotropy of fluorescent-labeled lysophospholipid and taurodeoxycholate aggregates.Biophys J. 1996 Mar;70(3):1466-71. doi: 10.1016/S0006-3495(96)79707-2. Biophys J. 1996. PMID: 8785303 Free PMC article.
-
Interaction of lysophospholipid/taurodeoxycholate submicellar aggregates with phospholipid bilayers.Biochemistry. 1992 Apr 7;31(13):3414-20. doi: 10.1021/bi00128a016. Biochemistry. 1992. PMID: 1554723
-
Bile salt-phospholipid aggregation at submicellar concentrations.Colloids Surf B Biointerfaces. 2008 Apr 1;62(2):238-42. doi: 10.1016/j.colsurfb.2007.10.008. Epub 2007 Oct 22. Colloids Surf B Biointerfaces. 2008. PMID: 18035524
-
Physical chemistry of biliary lipids during bile formation.Hepatology. 1990 Sep;12(3 Pt 2):143S-147S; discussion 147S-148S. Hepatology. 1990. PMID: 2210642 Review.
-
Quasielastic light scattering studies of aqueous biliary lipid systems and native bile.Hepatology. 1990 Sep;12(3 Pt 2):39S-44S. Hepatology. 1990. PMID: 2210655 Review.
Cited by
-
Kinetics and thermodynamics of association of a fluorescent lysophospholipid derivative with lipid bilayers in liquid-ordered and liquid-disordered phases.Biophys J. 2005 Jun;88(6):4064-71. doi: 10.1529/biophysj.104.054007. Epub 2005 Mar 25. Biophys J. 2005. PMID: 15792982 Free PMC article.
-
Effect of bile salts on monolayer curvature of a phosphatidylethanolamine/water model membrane system.Biophys J. 1991 Sep;60(3):728-32. doi: 10.1016/S0006-3495(91)82103-8. Biophys J. 1991. PMID: 1932556 Free PMC article.
-
Time-resolved fluorescence anisotropy of fluorescent-labeled lysophospholipid and taurodeoxycholate aggregates.Biophys J. 1996 Mar;70(3):1466-71. doi: 10.1016/S0006-3495(96)79707-2. Biophys J. 1996. PMID: 8785303 Free PMC article.
-
Oxidized phospholipids as potential novel drug targets.Biophys J. 2007 Nov 1;93(9):3105-12. doi: 10.1529/biophysj.107.103887. Epub 2007 Jun 29. Biophys J. 2007. PMID: 17604316 Free PMC article.
-
Altered migrating myoelectrical complex in an animal model of cholesterol gallstone disease: the effect of erythromycin.Gut. 1998 Dec;43(6):817-22. doi: 10.1136/gut.43.6.817. Gut. 1998. PMID: 9824610 Free PMC article.